title: Anesthetic management and perioperative complications in transcatheter aortic valve implantation: the Turkish experience.
abstract: OBJECTIVE
  To describe the anesthetic management and early results of transcatheter aortic valve implantation (TAVI) in a single center in Turkey.
  
  
  METHODS
  We evaluated 79 (54 females, 25 males; mean age: 76 ± 9 years) consecutive symptomatic patients with severe aortic stenosis who underwent TAVI under general anesthesia between July 2011 and September 2012. We preferred a transfemoral approach as the first option.
  
  
  RESULTS
  The duration of anesthesia was 149 ± 49 min. Thirty-eight percent of the patients were extubated in the cardiac catheterization laboratory. Three patients required a permanent pacemaker, while 8 patients required inotropic support in the postoperative period. Mortality rate was 9% within 30 days. Fifteen patients had vascular complications, of which 53% were treated surgically.
  
  
  CONCLUSIONS
  Today, as a result of developments in technology, TAVI can be considered as a beneficial alternative treatment option for inoperable aortic stenosis patients. Thus, anesthesiologists will be confronted with a number of TAVI cases, and so they should be prepared to face issues related to the patient's safety both during the administration of anesthesia and in the postoperative period in the near future.
authors.affiliation: Department of Anesthesia and Reanimation, Atatürk Education and Research Hospital, Ankara, Turkey.
authors.forename: Tülin
authors.initials: T
authors.lastname: Gümüş
authors.forename: Elvin
authors.initials: E
authors.lastname: Kesimci
authors.forename: Cem
authors.initials: C
authors.lastname: Soykut
authors.forename: Orhan
authors.initials: O
authors.lastname: Kanbak
authors.forename: Abdülkadir
authors.initials: A
authors.lastname: But
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D058109:Airway Management; D000768:Anesthesia, General; D001024:Aortic Valve Stenosis / Q000150:complications / Q000401:mortality / Q000601:surgery*; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D012189:Retrospective Studies; D065467:Transcatheter Aortic Valve Replacement / Q000009:adverse effects*; D016896:Treatment Outcome; D014421:Turkey